WAM
BSX icon

Wakefield Asset Management’s Boston Scientific BSX Stock Holding History

Wakefield Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,600
Closed -$387K – 199
2025
Q2 		$387K Buy
+3,600
New +$364K 0.11% 177

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wakefield Asset Management's BSX Position: Q3 2025 in Review

Wakefield Asset Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 3,600 shares — an estimated $387K sold.

Wakefield Asset Management first reported a position in BSX in Q2 2025 and held it in 1 quarter. The position peaked at $387K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Wakefield Asset Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Wakefield Asset Management sold 3,600 Boston Scientific shares in Q3 2025, an estimated $387K.
  • Wakefield Asset Management first reported a position in Boston Scientific in Q2 2025 and held it in 1 quarter.
  • Wakefield Asset Management's Boston Scientific position peaked at $387K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Wakefield Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.